(-)-demecolcine increases expression EXP 6480464 Demecolcine results in increased expression of H2BC12 mRNA CTD PMID:23649840 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of H2BC12 mRNA CTD PMID:22574217 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1593016 6480464 Tetrachlorodibenzodioxin results in decreased expression of H2BC12 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1618808 6480464 Tetrachlorodibenzodioxin affects the expression of H2BC12 mRNA CTD PMID:21570461 , PMID:24680724 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1618808 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of H2BC12 mRNA CTD PMID:25975270 2-hydroxypropanoic acid increases expression EXP 6480464 Lactic Acid results in increased expression of H2BC12 mRNA CTD PMID:30851411 5-fluorouracil decreases expression EXP 6480464 Fluorouracil results in decreased expression of H2BC12 mRNA CTD PMID:16101138 5-fluorouracil affects response to substance EXP 6480464 H2BC12 protein affects the susceptibility to Fluorouracil CTD PMID:15352031 , PMID:16217747 5-fluorouracil increases expression EXP 6480464 Fluorouracil results in increased expression of H2BC12 protein CTD PMID:15352031 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of H2BC12 mRNA CTD PMID:27153756 all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of H2BC12 mRNA CTD PMID:21934132 , PMID:23724009 aminoglutethimide increases expression EXP 6480464 Aminoglutethimide results in increased expression of H2BC12 protein CTD PMID:26102013 Aroclor 1254 increases expression ISO RGD:1618808 6480464 Chlorodiphenyl 54% Chlorine results in increased expression of H2BC12 mRNA CTD PMID:23650126 belinostat multiple interactions EXP 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of H2BC12 mRNA CTD PMID:27188386 belinostat decreases expression EXP 6480464 belinostat results in decreased expression of H2BC12 mRNA CTD PMID:26272509 , PMID:27188386 benzene decreases expression EXP 6480464 Benzene results in decreased expression of H2BC12 mRNA CTD PMID:19162166 benzo[a]pyrene increases expression EXP 6480464 Benzoapyrene results in increased expression of H2BC12 mRNA CTD PMID:20106945 benzo[a]pyrene increases expression ISO RGD:1618808 6480464 Benzoapyrene results in increased expression of H2BC12 mRNA CTD PMID:22228805 , PMID:22610609 benzo[a]pyrene diol epoxide I increases expression EXP 6480464 7 more ... CTD PMID:20382639 berberine decreases expression EXP 6480464 Berberine results in decreased expression of H2BC12 mRNA CTD PMID:27311644 bleomycin A5 decreases expression EXP 6480464 bleomycetin results in decreased expression of H2BC12 mRNA CTD PMID:21040473 cadmium atom increases expression EXP 6480464 Cadmium results in increased expression of H2BC12 mRNA CTD PMID:24376830 chloropicrin decreases expression EXP 6480464 chloropicrin results in decreased expression of H2BC12 mRNA CTD PMID:26352163 ciguatoxin CTX1B affects expression ISO RGD:1618808 6480464 Ciguatoxins affects the expression of H2BC12 mRNA CTD PMID:18353800 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of H2BC12 mRNA CTD PMID:27594783 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of H2BC12 mRNA CTD PMID:19320972 copper atom multiple interactions EXP 6480464 [Disulfiram binds to Copper] which results in decreased expression of H2BC12 mRNA CTD PMID:24690739 copper(0) multiple interactions EXP 6480464 [Disulfiram binds to Copper] which results in decreased expression of H2BC12 mRNA CTD PMID:24690739 copper(II) sulfate increases expression EXP 6480464 Copper Sulfate results in increased expression of H2BC12 mRNA CTD PMID:19549813 coumestrol decreases expression EXP 6480464 Coumestrol results in decreased expression of H2BC12 mRNA CTD PMID:19167446 cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of H2BC12 mRNA CTD PMID:20106945 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of H2BC12 mRNA CTD PMID:27989131 dioxygen decreases expression EXP 6480464 Oxygen deficiency results in decreased expression of H2BC12 mRNA CTD PMID:26516004 disulfiram multiple interactions EXP 6480464 [Disulfiram binds to Copper] which results in decreased expression of H2BC12 mRNA CTD PMID:24690739 dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 doxorubicin affects expression EXP 6480464 Doxorubicin affects the expression of H2BC12 protein CTD PMID:29385562 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of H2BC12 mRNA CTD PMID:29803840 entinostat multiple interactions EXP 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of H2BC12 mRNA CTD PMID:27188386 entinostat decreases expression EXP 6480464 entinostat results in decreased expression of H2BC12 mRNA CTD PMID:26272509 ethanol multiple interactions EXP 6480464 [Ethanol co-treated with Folic Acid] results in decreased expression of H2BC12 mRNA CTD PMID:23378141 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of H2BC12 mRNA CTD PMID:23378141 folic acid multiple interactions EXP 6480464 [Ethanol co-treated with Folic Acid] results in decreased expression of H2BC12 mRNA CTD PMID:23378141 formaldehyde increases expression EXP 6480464 Formaldehyde results in increased expression of H2BC12 mRNA CTD PMID:23649840 hydrogen peroxide affects expression EXP 6480464 Hydrogen Peroxide affects the expression of H2BC12 mRNA CTD PMID:21179406 isotretinoin decreases expression EXP 6480464 Isotretinoin results in decreased expression of H2BC12 mRNA CTD PMID:20436886 methyl methacrylate increases expression ISO RGD:1618808 6480464 Methylmethacrylate results in increased expression of H2BC12 mRNA CTD PMID:16916219 methyl methanesulfonate increases expression EXP 6480464 Methyl Methanesulfonate results in increased expression of H2BC12 mRNA CTD PMID:23649840 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine increases expression EXP 6480464 N more ... CTD PMID:19013360 N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of H2BC12 mRNA, 1-Methyl-4-phenylpyridinium results in decreased expression of H2BC12 protein CTD PMID:24806433 , PMID:24810058 panobinostat decreases expression EXP 6480464 Panobinostat results in decreased expression of H2BC12 mRNA CTD PMID:26272509 panobinostat multiple interactions EXP 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of H2BC12 mRNA CTD PMID:27188386 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of H2BC12 mRNA CTD PMID:21420995 pirinixic acid increases expression ISO RGD:1618808 6480464 pirinixic acid results in increased expression of H2BC12 mRNA CTD PMID:23811191 potassium chromate increases expression EXP 6480464 potassium chromateVI results in increased expression of H2BC12 mRNA CTD PMID:22714537 rac-lactic acid increases expression EXP 6480464 Lactic Acid results in increased expression of H2BC12 mRNA CTD PMID:30851411 SB 431542 multiple interactions EXP 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 silicon dioxide increases expression EXP 6480464 Silicon Dioxide analog results in increased expression of H2BC12 mRNA CTD PMID:23806026 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of H2BC12 mRNA CTD PMID:22714537 , PMID:28595984 tert-butyl hydroperoxide increases expression EXP 6480464 tert-Butylhydroperoxide results in increased expression of H2BC12 mRNA CTD PMID:15336504 thalidomide decreases expression ISO RGD:1618808 6480464 Thalidomide results in decreased expression of H2BC12 mRNA CTD PMID:26217789 trichostatin A decreases expression EXP 6480464 trichostatin A results in decreased expression of H2BC12 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions EXP 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of H2BC12 mRNA CTD PMID:27188386 troglitazone increases expression EXP 6480464 Troglitazone results in increased expression of H2BC12 mRNA CTD PMID:19140230 urethane increases expression EXP 6480464 Urethane results in increased expression of H2BC12 mRNA CTD PMID:28818685 valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of H2BC12 mRNA CTD PMID:25979313 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of H2BC12 mRNA CTD PMID:28001369 valproic acid multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of H2BC12 mRNA CTD PMID:27188386 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of H2BC12 mRNA CTD PMID:23179753 more ... vinclozolin decreases expression ISO RGD:1593016 6480464 vinclozolin results in decreased expression of H2BC12 mRNA CTD PMID:23034163 vincristine increases expression EXP 6480464 Vincristine results in increased expression of H2BC12 mRNA CTD PMID:23649840 zinc sulfate decreases expression EXP 6480464 Zinc Sulfate results in decreased expression of H2BC12 mRNA CTD PMID:19013360 zoledronic acid increases expression EXP 6480464 Zoledronic Acid results in increased expression of H2BC12 mRNA CTD PMID:24714768